|
1
|
Sobacchi C, Schulz A, Coxon FP, Villa A
and Helfrich MH: Osteopetrosis: Genetics, treatment and new
insights into osteoclast function. Nat Rev Endocrinol. 9:522–536.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stark Z and Savarirayan R: Osteopetrosis.
Orphanet J Rare Dis. 4:52009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Deng H, He D, Rong P, Xu H, Yuan L, Li L,
Lu Q and Guo Y: Novel CLCN7 mutation identified in a Han Chinese
family with autosomal dominant osteopetrosis-2. Mol Pain.
12:17448069166526282016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Palagano E, Blair HC, Pangrazio A,
Tourkova I, Strina D, Angius A, Cuccuru G, Oppo M, Uva P, Van Hul
W, et al: Buried in the middle but guilty: Intronic mutations in
the TCIRG1 gene cause human autosomal recessive osteopetrosis. J
Bone Miner Res. 30:1814–1821. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Del Fattore A, Cappariello A and Teti A:
Genetics, pathogenesis and complications of osteopetrosis. Bone.
42:19–29. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Waguespack SG, Koller DL, White KE,
Fishburn T, Carn G, Buckwalter KA, Johnson M, Kocisko M, Evans WE,
Foroud T and Econs MJ: Chloride channel 7 (ClCN7) gene mutations
and autosomal dominant osteopetrosis, type II. J Bone Miner Res.
18:1513–1518. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Van Wesenbeeck L, Cleiren E, Gram J, Beals
RK, Bénichou O, Scopelliti D, Key L, Renton T, Bartels C, Gong Y,
et al: Six novel missense mutations in the LDL receptor-related
protein 5 (LRP5) gene in different conditions with an increased
bone density. Am J Hum Genet. 272:763–771. 2003. View Article : Google Scholar
|
|
8
|
Kornak U, Kasper D, Bösl MR, Kaiser E,
Schweizer M, Schulz A, Friedrich W, Delling G and Jentsch TJ: Loss
of the ClC-7 chloride channel leads to osteopetrosis in mice and
man. Cell. 104:205–215. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pangrazio A, Pusch M, Caldana E, Frattini
A, Lanino E, Tamhankar PM, Phadke S, Lopez AG, Orchard P, Mihci E,
et al: Molecular and clinical heterogeneity in CLCN7-dependent
osteopetrosis: Report of 20 novel mutations. Hum Mutat.
31:E1071–E1080. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Balemans W, Van Wesenbeeck L and Van Hul
W: A clinical and molecular overview of the human osteopetroses.
Calcif Tissue Int. 77:263–274. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Del Fattore A, Peruzzi B, Rucci N, Recchia
I, Cappariello A, Longo M, Fortunati D, Ballanti P, Iacobini M,
Luciani M, et al: Clinical, genetic, and cellular analysis of 49
osteopetrotic patients: Implications for diagnosis and treatment. J
Med Genet. 43:315–325. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cleiren E, Bénichou O, Van Hul E, Gram J,
Bollerslev J, Singer FR, Beaverson K, Aledo A, Whyte MP, Yoneyama
T, et al: Albers-Schönberg disease (autosomal dominant
osteopetrosis, type II) results from mutations in the ClCN7
chloride channel gene. Hum Mol Genet. 10:2861–2867. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lam CW, Tong SF, Wong K, Luo YF, Tang HY,
Ha SY and Chan MH: DNA-based diagnosis of malignant osteopetrosis
by whole-genome scan using a single-nucleotide polymorphism
microarray: Standardization of molecular investigations of genetic
diseases due to consanguinity. J Hum Genet. 52:98–101. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mazzolari E, Forino C, Razza A, Porta F,
Villa A and Notarangelo LD: A single-center experience in 20
patients with infantile malignant osteopetrosis. Am J Hematol.
84:473–479. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li N, Yang Y, Bu J, Zhao C, Lu S, Zhao J,
Yan L, Cui L, Zheng R, Li J, et al: An autosomal dominant
progressive congenital zonular nuclear cataract linked to
chromosome 20p12.2-p11.23. Mol Vis. 12:1506–1510. 2006.PubMed/NCBI
|
|
16
|
Alam I, Gray AK, Chu K, Ichikawa S,
Mohammad KS, Capannolo M, Capulli M, Maurizi A, Muraca M, Teti A,
et al: Generation of the first autosomal dominant osteopetrosis
type II (ADO2) disease models. Bone. 59:66–75. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Coudert AE, de Vernejoul MC, Muraca M and
Del Fattore A: Osteopetrosis and its relevance for the discovery of
new functions associated with the skeleton. Int J Endocrinol.
2015:3721562015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Aggarwal S: Skeletal dysplasias with
increased bone density: Evolution of molecular pathogenesis in the
last century. Gene. 528:41–45. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang C, Zhang H, He JW, Gu JM, Hu WW, Hu
YQ, Li M, Liu YJ, Fu WZ, Yue H, et al: The virulence gene and
clinical phenotypes of osteopetrosis in the Chinese population: Six
novel mutations of the CLCN7 gene in twelve osteopetrosis families.
J Bone Miner Metab. 30:338–348. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chu K, Koller DL, Snyder R, Fishburn T,
Lai D, Waguespack SG, Foroud T and Econs MJ: Analysis of variation
in expression of autosomal dominant osteopetrosis type 2: Searching
for modifier genes. Bone. 37:655–661. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Frattini A, Pangrazio A, Susani L,
Sobacchi C, Mirolo M, Abinun M, Andolina M, Flanagan A, Horwitz EM,
Mihci E, et al: Chloride channel ClCN7 mutations are responsible
for severe recessive, dominant, and intermediate osteopetrosis. J
Bone Miner Res. 18:1740–1747. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yu T, Yu Y, Wang J, Yin L, Zhou Y, Ying D,
Huang R, Chen H, Wu S, Shen Y, et al: Identification of TCIRG1 and
CLCN7 gene mutations in a patient with autosomal recessive
osteopetrosis. Mol Med Rep. 9:1191–1196. 2014. View Article : Google Scholar : PubMed/NCBI
|
